BARCLAYS PLC - ATEA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$77
+35.1%
25,619
+67.8%
0.00%
Q2 2023$57
-56.2%
15,271
-60.6%
0.00%
Q1 2023$130
+3.2%
38,759
+48.6%
0.00%
Q4 2022$126
-99.9%
26,082
-29.6%
0.00%
Q3 2022$211,000
-36.6%
37,023
-21.1%
0.00%
Q2 2022$333,000
-25.7%
46,940
-24.3%
0.00%
Q1 2022$448,00062,0100.00%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,485,638$22,222,0001.76%
EcoR1 Capital, LLC 5,376,134$48,063,0001.53%
Cormorant Asset Management, LP 1,679,442$15,014,0000.89%
CM Management, LLC 100,000$894,0000.68%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 596,800$5,335,0000.40%
PDT Partners, LLC 278,487$2,490,0000.19%
Ikarian Capital, LLC 116,600$1,043,0000.16%
HighVista Strategies LLC 20,659$185,0000.15%
Aristides Capital LLC 35,132$314,0000.14%
Parkwood LLC 71,932$643,0000.11%
View complete list of ATEA PHARMACEUTICALS INC shareholders